Bixiye
P40-17 New Prior Authorization Requirements for Immunomodular Drugs
Taariikhda dhaqangalka Barnaamijka: Jul 12, 2017
Natiijooyinka Raadinta
Soo bandhiga 3151 - 3160 ee natiijooyinka 4130
Bixiye
P20-18 2018 Renewal Changes Summary For Blue Plus Referral Health Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2018
Bixiye
P38-17 New Drug-Related Prior Authorization (PA) for Xolair
Taariikhda dhaqangalka Barnaamijka: Jul 05, 2017
Bixiye
P28-18 Change to Administration of Interpreter Services for MHCP Subscribers
Taariikhda wax ku ool ah ee barnaamijka: Jun 28, 2018
Bixiye
2018 July Bulletins
Taariikhda dhaqangalka Barnaamijka: Jul 02, 2018
Bixiye
P62-17 Addition of Drug to the Parathyroid Hormone Analog for Osteoporosis Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Bixiye
P22-18 2018 Renewal Changes Summary For Suppliers Of Durable Medical Equipment (DME)
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2018
Bixiye
P67-17 PA Requirements for New Medicare Advantage Prescription Drug Products in 2018
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Bixiye
P79-17 Clarification to MHCP PA Requirements for Pelvic Floor Stimulator
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2017
Bixiye
P83-17 Clarification to MHCP Prior Authorization Requirements for Nusinersen (Spinraza)
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2017